Volume | 335 |
|
|||||
News | - | ||||||
Day High | 8.83 | Low High |
|||||
Day Low | 8.83 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Daxor Corporation | DXR | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
8.83 | 8.83 | 8.83 | 9.00 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
2 | 335 | US$ 8.83 | US$ 2,958 | - | 7.11 - 10.1499 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
08:30:03 | 335 | US$ 8.83 | USD |
Daxor Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
37.77M | 4.20M | - | 163k | 281k | 0.07 | 134.33 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Daxor News
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DXR Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 8.86 | 9.6001 | 8.55 | 8.83 | 1,022 | -0.03 | -0.34% |
1 Month | 9.41 | 9.685 | 8.20 | 9.07 | 1,134 | -0.58 | -6.16% |
3 Months | 8.50 | 9.9999 | 8.11 | 9.44 | 2,222 | 0.33 | 3.88% |
6 Months | 7.16 | 10.04 | 7.16 | 9.11 | 2,664 | 1.67 | 23.32% |
1 Year | 9.55 | 10.1499 | 7.11 | 9.16 | 2,643 | -0.72 | -7.54% |
3 Years | 10.97 | 14.55 | 7.11 | 10.20 | 3,957 | -2.14 | -19.51% |
5 Years | 10.97 | 14.55 | 7.11 | 10.20 | 3,957 | -2.14 | -19.51% |
Daxor Description
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. It develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions. |